Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ágoston Ember is active.

Publication


Featured researches published by Ágoston Ember.


European Archives of Oto-rhino-laryngology | 2011

Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers

István Szanyi; Miklós Bauer; Imre Gerlinger; Tamás Járai; Gyula Gőbel; László Lujber; Éva Szabadi; Katalin Fehér; Ágoston Ember; István Ember; István Kiss

Despite modern diagnostic procedures and up-to-date therapy, the survival of head and neck tumour patients is unfavourable. This can be explained by several factors, one of which is the late recognition of the tumour. This study related to the changes in expression of the c-myc and Ha-ras oncogenes and the p53 tumour suppressor gene as biomarkers in head and neck cancer cases. The gene expressions were investigated on RNA gained from peripheral white blood cells of head and neck cancers patients before and after definitive treatment. The results were compared with those on a control group of patients with non-tumorous diseases. The gene expressions were significantly higher in the cancer group than that in the control group (volunteer medical staff and medical students). After definitive treatment, the expressions of all these genes were decreased in patients in whom there was no recurrence of the tumour, but enhanced in the event of recurrence. Such measurement may serve as reliable biomarkers to monitor tumour development and the efficiency of therapy. The method may also be useful for the early identification of populations exposed to noxe, which may lead to the development of head and neck cancers.


Orvosi Hetilap | 2011

Impact of microRNAs on molecular epidemiology

Katalin Gocze; Katalin Gombos; Gábor Pajkos; Ingrid Magda; Ágoston Ember; Krisztina Juhász; Balázs Patczai; István Ember

Cancer research concerning short non-coding RNA sequences and functionally linked to RNA interference (RNAi) have reached explosive breakthrough in the past decade. Molecular technology applies microRNA in extremely wide spectrum from molecular tumor prediction, diagnostics, progression monitoring and prevention. Functional analysis of tissue miRNA and cell-free serum miRNA in posttranscription and translation regulation innovated and restructured the knowledge on the field. This review focuses on molecular epidemiology and primary prevention aspects of the small non-coding RNA sequences.


Magyar sebészet | 2009

Különleges eredetű feszülő légmellr

Ágoston Ember; Balázs Ittzés; Veronika Heckmann; Andrea Jegesy; Terézia László; Tamás Molnár F.

CASE REPORT A middle-aged man presented with the diagnosis of typical spontaneous pneumothorax in the left chest. His management was initiated as usual with a chest drain and he had an uneventful recovery with good expansion of the affected lung up until the third postoperative day. But due to a fatal accident, the patient connected the oxygene supply tube into his thoracic drain. This high pressure caused a left, and a consequent bilateral pneumothorax with massive subcutanous emphysema, being the cause of a preterminal status. Cardio-pulmonary resuscitation was unsuccesfull and the patient died. Intentional suicide was excluded by forensic investigations. DISCUSSION According to our knowledge, no similar case with this mechanism of tension pnemuthorax has been published in the literature so far. The pathophysiology is similar to lung damage due to high-pressure ventillation with consecutive tension pneumothorax.


Anticancer Research | 2008

GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer

Andras Csejtei; Antal Tibold; Zsuzsa Varga; Katalin Koltai; Ágoston Ember; Zsuzsa Orsós; Gergely Feher; Ors Peter Horvath; István Ember; István Kiss


in Vivo | 2009

Early Modification of c-myc, Ha-ras and p53 Expressions by Chemical Carcinogens (DMBA, MNU)

Ferenc Budán; Tímea Varjas; Ghodratollah Nowrasteh; Ida Prantner; Zsuzsa Varga; Ágoston Ember; József Cseh; Katalin Gombos; Emese Pázsit; Gyula Gobel; Miklós Bauer; Tünde Gracza; Istvan Arany; P. Á L Perjési; István Ember; István Kiss


Anticancer Research | 2003

Early effects of different cytostatic protocols for head and neck cancer on oncogene activation in animal experiments.

Árpád Németh; Edit Nádasi; Gyöngyi Z; Lajos Olasz; Nyarady Z; Ágoston Ember; Kvarda A; Bujdoso L; I. Arany; István Kiss; Csejtey I; István Ember


Anticancer Research | 2004

Early Effects of Transplatin on Oncogene Activation In Vivo

Árpád Németh; Edit Nádasi; A. Beró; Lajos Olasz; Ágoston Ember; A. Kvarda; L. Bujdosó; I. Arany; A. Csejtei; Zs Faluhelyi; István Ember


in Vivo | 2009

The plant-derived natural compound Flavin 7® attenuates oxidative stress in cultured renal proximal tubule cells

Ágoston Ember; Jeb S. Clark; Tímea Varjas; István Kiss; István Ember; Radhakrishna Baliga; Istvan Arany


Magyar sebészet | 2006

[Complete regression after neoadjuvant chemotherapy in locally advanced gastric cancer causing peritonitis carcinomatosa--a case report].

Ágoston Ember; Al Farhat Yousuf; Katalin Kalmár; András Papp; Olga Ésik; Örs Péter Horváth


European Journal of Oncology | 2011

Colon-rectum (C18.9-20.9) Application of molecular epidemiological biomarkers by monitoring the effects of treatment in colorectal cancer during follow-up study / Applicazione di biomarkers molecolari epidemiologici mediante il monitoraggio degli effetti del trattamento nel cancro colorettale durante uno studio di follow-up

Ágoston Ember; Ferenc Budán; Ghodratollah Nowrasteh

Collaboration


Dive into the Ágoston Ember's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge